CR9020A - Utilizacion de un compuesto antiaterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares - Google Patents

Utilizacion de un compuesto antiaterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares

Info

Publication number
CR9020A
CR9020A CR9020A CR9020A CR9020A CR 9020 A CR9020 A CR 9020A CR 9020 A CR9020 A CR 9020A CR 9020 A CR9020 A CR 9020A CR 9020 A CR9020 A CR 9020A
Authority
CR
Costa Rica
Prior art keywords
treatment
obtaining
vascular disorders
antiaterotrombotic
medicines
Prior art date
Application number
CR9020A
Other languages
English (en)
Inventor
Fratacci Marie-Dominique
De Cordoue Agnes
Lerond Laurence
Verbeuren Tony
Rupin Alain
Lavielle Gilbert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CR9020A publication Critical patent/CR9020A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a la utilizacion de un antagonista especifico de los receptores TP para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares en el paciente que presenta un antecedente de accidente vascular cerebral, especialmente para la reduccion de los sucesos cerebro-vasculares y cardiovasculares en los pacientes que presentan un antecedente de accidente isquemico cerebral (AIC) o de ataque isquemico transitorio (AIT).
CR9020A 2006-04-07 2007-03-28 Utilizacion de un compuesto antiaterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares CR9020A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603082A FR2899473B1 (fr) 2006-04-07 2006-04-07 Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires

Publications (1)

Publication Number Publication Date
CR9020A true CR9020A (es) 2008-09-23

Family

ID=37084627

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9020A CR9020A (es) 2006-04-07 2007-03-28 Utilizacion de un compuesto antiaterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares

Country Status (40)

Country Link
US (1) US20070238785A1 (es)
EP (2) EP2105132A1 (es)
JP (1) JP2009532447A (es)
KR (2) KR20070100658A (es)
CN (2) CN101693025A (es)
AP (1) AP2007003952A0 (es)
AR (1) AR060288A1 (es)
AT (1) ATE452633T1 (es)
AU (1) AU2007201525A1 (es)
BR (1) BRPI0701597A (es)
CA (1) CA2582394A1 (es)
CO (1) CO5820217A1 (es)
CR (1) CR9020A (es)
CY (1) CY1109793T1 (es)
DE (1) DE602007003880D1 (es)
DK (1) DK1842537T3 (es)
EA (1) EA013874B1 (es)
ES (1) ES2338600T3 (es)
FR (1) FR2899473B1 (es)
GE (1) GEP20094782B (es)
GT (1) GT200700029A (es)
HR (1) HRP20100091T1 (es)
IL (1) IL182406A0 (es)
MA (1) MA28988B1 (es)
MX (1) MX2007004108A (es)
NI (1) NI200700083A (es)
NO (1) NO20071833L (es)
NZ (1) NZ554348A (es)
PE (1) PE20071147A1 (es)
PL (1) PL1842537T3 (es)
PT (1) PT1842537E (es)
RS (1) RS51207B (es)
SG (1) SG136882A1 (es)
SI (1) SI1842537T1 (es)
SV (1) SV2008003053A (es)
TN (1) TNSN07117A1 (es)
TW (1) TW200808306A (es)
UY (1) UY30263A1 (es)
WO (1) WO2007116138A1 (es)
ZA (1) ZA200702866B (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
RU2120292C1 (ru) * 1992-07-22 1998-10-20 Российско-германское акционерное общество закрытого типа "УТИЛЕКС" Способ лечения мозговых сосудистых кризов
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE4343776A1 (de) * 1993-12-17 1995-06-22 Schering Ag Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JPH08119936A (ja) * 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2860436B1 (fr) * 2003-10-03 2006-01-20 Servier Lab Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire

Also Published As

Publication number Publication date
PE20071147A1 (es) 2007-12-22
MX2007004108A (es) 2009-02-16
ES2338600T3 (es) 2010-05-10
ATE452633T1 (de) 2010-01-15
CN101693025A (zh) 2010-04-14
SI1842537T1 (sl) 2010-03-31
NI200700083A (es) 2008-06-09
FR2899473A1 (fr) 2007-10-12
NO20071833L (no) 2007-10-08
UY30263A1 (es) 2007-05-31
SV2008003053A (es) 2009-12-02
FR2899473B1 (fr) 2008-06-13
EP2105132A1 (fr) 2009-09-30
CY1109793T1 (el) 2014-09-10
TW200808306A (en) 2008-02-16
US20070238785A1 (en) 2007-10-11
RS51207B (sr) 2010-12-31
JP2009532447A (ja) 2009-09-10
HRP20100091T1 (hr) 2010-04-30
DE602007003880D1 (de) 2010-02-04
AU2007201525A1 (en) 2007-10-25
WO2007116138A1 (fr) 2007-10-18
KR20090086500A (ko) 2009-08-13
IL182406A0 (en) 2008-01-20
CA2582394A1 (fr) 2007-10-07
EP1842537A1 (fr) 2007-10-10
GEP20094782B (en) 2009-09-25
GT200700029A (es) 2007-10-31
MA28988B1 (fr) 2007-11-01
AR060288A1 (es) 2008-06-04
KR20070100658A (ko) 2007-10-11
SG136882A1 (en) 2007-11-29
EA013874B1 (ru) 2010-08-30
CO5820217A1 (es) 2007-11-30
AP2007003952A0 (en) 2007-04-30
EA200700573A3 (ru) 2007-12-28
PL1842537T3 (pl) 2010-06-30
BRPI0701597A (pt) 2007-12-11
PT1842537E (pt) 2010-01-15
ZA200702866B (en) 2008-07-30
CN101049292A (zh) 2007-10-10
NZ554348A (en) 2008-09-26
TNSN07117A1 (fr) 2008-06-02
EP1842537B1 (fr) 2009-12-23
EA200700573A2 (ru) 2007-10-26
DK1842537T3 (da) 2010-04-12

Similar Documents

Publication Publication Date Title
BR112018003845A2 (pt) auxiliares cirúrgicos com medicamentos afetados por materiais ativadores
GT201000182A (es) Regimen de dosificacion asociado con ésteres de paliperidona inyectables de acción prolongada
UY31314A1 (es) Amidas heterociclicas y sus métodos de uso-976
CY1113315T1 (el) Ιμιδαζολοκαρβοξαμιδια
CU23874B1 (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso
CL2007003262A1 (es) Compuestos derivados de 1,4-benzotiepina-1,1-dioxido; composicion farmaceutica; y su uso para el tratamiento de trastornos del metabolismo de lipidos, hiperlipidemia, resistencia a la insulina, diabetes y trastornos del snc, entre otras enfermedades.
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
CL2008003116A1 (es) Compuestos heterocíclicos bicíclicos; composición farmacéutica que comprende a dichos compuestos; y su uso en el tratamiento o prevención de enfermedades tales como diabetes, obesidad, trastorno metabólico, enfermedad cardiovascular entre otras.
CR20110509A (es) Composicion farmaceutica
GT200900175A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
EA202091999A3 (ru) Применение ингибиторов dpp iv
CO6251239A2 (es) Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo junto con un inhibidor de dpp iv
AR057946A1 (es) Formulacion de zonisamida de liberacion sostenidda
DK2319517T3 (da) Anvendelse af prodrugs til okulær, intravenøs administration
GT200600109A (es) Derivados de acido pirimidincarboxilico y su uso
UY31922A (es) Compuestos
BR112013024973A2 (pt) prevenção de hipoglicemia em pacientes com diabetes mellitus do tipo 2
BR112015017251A8 (pt) composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas
BRPI1007350B8 (pt) compostos espiro heterocíclicos bicíclicos
BRPI0513938A (pt) composição farmacêutica contendo drospirenona e etinilestradiol
BR112014031649A2 (pt) composto representado pela fórmula 1 tendo a enzima inibidora de atividade 11b-hsd1; método para sua produção e composição farmacêutica contendo o mesmo como ingrediente ativo
CL2013000709A1 (es) Composicion que contiene nifurtimox y un antihelmintico seleccionado de: pf1022, emopdepsido, tribendimidina, amidantel, bay d 9216, praziquantel o benzoato de bencilo; util en el tratamiento de enfermedades causadas por giardias (div. sol. 1577-10).
CR9020A (es) Utilizacion de un compuesto antiaterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares
BRPI0813658A2 (pt) composto, medicamento, composição farmacêutica, preparação farmacêutica combinada, usos de um composto e de uma preparação combinada, e, processo para a preparação de composto.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)